Vivera is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, advanced diagnostics, medical supplies, medical technologies, and neurosciences, the Company has global exclusivity to license the patented and patent-pending TABMELT®️ sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with technology, manufacturing capabilities, and distribution for its products.
Vivera is committed to the continued research and development of innovative therapies across the spectrum. We believe that now is the time to combat some of the most unprecedented issues affecting patients and their caregivers by redefining the landscape with safe, yet effective, non-addictive treatment alternatives for pain management and the latest in medical device technologies. From strength in vision to channeled realization, we believe the path forward begins with the requirement to put patients first. Our foremost mission is to enhance the lives of millions of neighbors, families, and the leaders of tomorrow, through ceaseless development of life-changing new therapies.
Vivera is dedicated to making a positive difference for vulnerable communities across the world. Through our non-profit organization, Vivera Cares, we are helping underserved communities, like Tribal Nations and frontline workers, access the resources they need to keep their communities safe and healthy. With our continued support, we can envision a brighter future for our communities, patients, and providers.
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company founded on the belief that patients should always come first, recognizes that mental health
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., congratulates its clinical research partner, Parexel International, on its $8.5 billion acquisition. The EQT IX fund and the
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc. and diagnostic testing distributor, Areum Bio LLC, today announce their channel partnership to expand the distribution of Access Bio,
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., is pleased to welcome Mr. Gonçalo Leal to the Scientific Advisory Board of the Company’s Neurosciences Division. With 15
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has welcomed Mr. Shawn Ray to the Company’s Ambassador Board. Mr. Ray will not
Esteemed pharmaceutical expert joins innovative Newport Beach pharmaceutical companyin pursuit of breakthrough medical developments NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical
Most people experience disfluencies while speaking from time to time. However, if disfluencies are the norm, then the cause may be a fluency disorder. A
There is a common misconception that those who use prescription medications to treat opioid use disorder (OUD) are trading one addiction for the other. While
Opioids are a class of drugs that work by binding the opioid receptors in the central nervous system. Opioids fall into three categories: prescription opioids, heroin,
The opioid epidemic refers to the three distinct waves of opioid-related overdose deaths, beginning in the 1990s with the over-prescription of pain medications. To help
Opioid addiction is a chronic, life-long disease characterized by a compulsive desire to seek and use opioids, regardless of any negative consequences. Like all addictions, opioid
There are many misconceptions regarding harm reduction strategies for opioid use disorder (OUD), such as the assumption that they deny the dangers of drugs and
Innovation is the lifeblood of Vivera. With six divisions, each focused on a specific crisis response, Vivera’s vertically integrated structure has created an agile and responsive model.
Vivera is working to change the future of drug delivery, medical device, and medical technologies at home and across the globe with its extensive intellectual property portfolio.
Copyright © 2021 Vivera Pharmaceuticals, Inc. All rights reserved.
This information – including product information – is intended only for certified clinicians in the United States. The products discussed herein may have different labeling in different countries. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
English
Arabic
Armenian
Chinese (Simplified)
Chinese (Traditional)
Czech
Dutch
Tagalog
French
Frisian
German
Irish
Italian
Korean
Farsi
Polish
Portuguese
Romanian
Russian
Spanish
Swedish
Ukrainian
Vietnamese